![Jennifer Peppe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Ms. Jennifer Peppe was previously employed as a Senior Vice President-Clinical Operations by Imago BioSciences, Inc., a Senior Director-Clinical Operations by FerroKin BioSciences, Inc., and an Associate Director by Genzyme Corp.
She received her undergraduate degree from Smith College.
Eerdere bekende functies van Jennifer Peppe
| Bedrijven | Functie | Einde |
|---|---|---|
FerroKin BioSciences, Inc.
 FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Offers iron chelator for the treatment of iron-overload in patients | Hoofd Techniek/Wetenschap/O&O | 01-01-2012 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| IMAGO BIOSCIENCES, INC. | Oprichter | - |
Opleiding van Jennifer Peppe
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
3
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Smith College
 Smith College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FerroKin BioSciences, Inc.
FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Offers iron chelator for the treatment of iron-overload in patients | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicines for the treatment of myeloproliferative neoplasms and bone marrow diseases | Health Technology |
